|
Code
|
80454
|
|
MA number
|
56/0564/09-S
|
|
Product Form:
|
imp 3x5 mg (striek.inj.napl.plast.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Sandoz Pharmaceuticals d.d., Slovenia
|
|
Therapeutic Class:
|
56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
|
|
ATC:
|
| L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L02 |
ENDOCRINE THERAPY |
| L02A |
HORMONES AND RELATED AGENTS |
| L02AE |
Gonadotropin releasing hormone analogues |
| L02AE02 |
Leuprorelin |
|
|
Shelf life:
|
48 |
|
Container:
|
pre-filled syringe PP
|
|
Route of admin.:
|
Subcutaneous use
|
SPC_Leuprorelin Sandoz 5 mg implantat_09_2024.pdf
